Role of fibroblast growth factor 8 in growth and progression of hormonal cancer

Cytokine and Growth Factor Reviews

Volumn 18, Issue 3-4, 2007, Pages 257-266

  Mattila, Mirjami M ^a   Härkönen, Pirkko L ^b  

^a UNIVERSITY OF TURKU   (Finland)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Angiogenesis; Breast cancer; FGF8; Proliferation; Prostate cancer

Indexed keywords

ANDROGEN; ESTROGEN; FIBROBLAST GROWTH FACTOR 8; GESTAGEN; GROWTH FACTOR; GROWTH FACTOR RECEPTOR;

BREAST CANCER; EMBRYO DEVELOPMENT; ENDOMETRIUM CARCINOMA; GASTRULATION; HORMONAL CARCINOGENESIS; HORMONAL REGULATION; OVARY CANCER; OVARY CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; SHORT SURVEY; TESTIS CARCINOMA; THYROID CARCINOMA; TUMOR GROWTH;

ANIMALS; CELL PROLIFERATION; FEMALE; FIBROBLAST GROWTH FACTOR 8; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MODELS, BIOLOGICAL; NEOPLASMS, HORMONE-DEPENDENT; NEOVASCULARIZATION, PATHOLOGIC; PROSTATIC NEOPLASMS; SIGNAL TRANSDUCTION; STEROIDS;

EID: 34249990979     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2007.04.010     Document Type: Short Survey

References (119)

1. Tanaka A., Miyamoto K., Minamino N., Takeda M., Sato B., Matsuo H., et al. Cloning and characterization of an androgen-induced growth factor essential for the androgen-dependent growth of mouse mammary carcinoma cells. Proc Natl Acad Sci USA 89 (1992) 8928-8932
2. Marsh S.K., Bansal G.S., Zammit C., Barnard R., Coope R., Roberts-Clarke D., et al. Increased expression of fibroblast growth factor 8 in human breast cancer. Oncogene 18 (1999) 1053-1060
3. Dorkin T.J., Robinson M.C., Marsh C., Bjartell A., Neal D.E., and Leung H.Y. FGF8 over-expression in prostate cancer is associated with decreased patient survival and persists in androgen independent disease. Oncogene 18 (1999) 2755-2761
4. Valve E., Martikainen P., Seppanen J., Oksjoki S., Hinkka S., Anttila L., et al. Expression of fibroblast growth factor (FGF)-8 isoforms and FGF receptors in human ovarian tumors. Int J Cancer 88 (2000) 718-725
5. Dorkin T.J., Bjartell A., Neal D.E., and Leung H.Y. FGF-8 expression in prostatic bone and lymph node metastases. BJU Int 86 (2000) 392-393
6. Darby S., Sahadevan K., Khan M.M., Robson C.N., Leung H.Y., and Gnanapragasam V.J. Loss of Sef (similar expression to FGF) expression is associated with high grade and metastatic prostate cancer. Oncogene 25 (2006) 4122-4127
7. Tanaka A., Miyamoto K., Matsuo H., Matsumoto K., and Yoshida H. Human androgen-induced growth factor in prostate and breast cancer cells: its molecular cloning and growth properties. FEBS Lett 363 (1995) 226-230
8. Daphna-Iken D., Shankar D.B., Lawshe A., Ornitz D.M., Shackleford G.M., and MacArthur C.A. MMTV-Fgf8 transgenic mice develop mammary and salivary gland neoplasia and ovarian stromal hyperplasia. Oncogene 17 (1998) 2711-2717
9. Song Z., Powell W.C., Kasahara N., van Bokhoven A., Miller G.J., and Roy-Burman P. The effect of fibroblast growth factor 8, isoform b, on the biology of prostate carcinoma cells and their interaction with stromal cells. Cancer Res 60 (2000) 6730-6736
10. Mattila M.M., Ruohola J.K., Valve E.M., Tasanen M.J., Seppänen J.A., and Härkönen P.L. FGF-8b increases angiogenic capacity and tumor growth of androgen-regulated S115 breast cancer cells. Oncogene 20 (2001) 2791-2804
11. Ruohola J.K., Viitanen T.P., Valve E.M., Seppänen J.A., Loponen N.T., Keskitalo J.J., et al. Enhanced invasion and tumor growth of fibroblast growth factor 8b-overexpressing MCF-7 human breast cancer cells. Cancer Res 61 (2001) 4229-4237
12. Song Z., Wu X., Powell W.C., Cardiff R.D., Cohen M.B., Tin R.T., et al. Fibroblast growth factor 8 isoform b overexpression in prostate epithelium: a new mouse model for prostatic intraepithelial neoplasia. Cancer Res 62 (2002) 5096-5105
13. Zhong C., Saribekyan G., Liao C., Cohen M.B., and Roy-Burman P. Cooperation between FGF8b overexpression and PTEN deficiency in prostate tumorigenesis. Cancer Res 66 (2006) 2188-2194
14. Ghosh A., Shankar D.B., Shackleford G.M., Wu K., T'Ang A., Miller G.J., et al. Molecular cloning and characterization of human FGF8 alternative messenger RNA forms. Cell Growth Differ 7 (1996) 1425-1434
15. Valve E., Penttilä T.L., Paranko J., and Härkönen P. FGF-8 is expressed during specific phases of rodent oocyte and spermatogonium development. Biochem Biophys Res Commun 232 (1997) 173-177
16. Tanaka A., Furuya A., Yamasaki M., Hanai N., Kuriki K., Kamiakito T., et al. High frequency of fibroblast growth factor (FGF) 8 expression in clinical prostate cancers and breast tissues, immunohistochemically demonstrated by a newly established neutralizing monoclonal antibody against FGF8. Cancer Res 58 (1998) 2053-2056
17. Valve E.M., Nevalainen M.T., Nurmi M.J., Laato M.K., Martikainen P.M., and Härkönen P.L. Increased expression of FGF-8 isoforms and FGF receptors in human premalignant prostatic intraepithelial neoplasia (PIN) lesions and prostate cancer. Lab Invest 81 (2001) 815-826
18. Nezu M., Tomonaga T., Sakai C., Ishii A., Itoga S., Nishimura M., et al. Expression of the fetal-oncogenic fibroblast growth factor-8/17/18 subfamily in human hematopoietic tumors. Biochem Biophys Res Commun 335 (2005) 843-849
19. Ohuchi H., Yoshioka H., Tanaka A., Kawakami Y., Nohno T., and Noji S. Involvement of androgen-induced growth factor (FGF-8) gene in mouse embryogenesis and morphogenesis. Biochem Biophys Res Commun 204 (1994) 882-888
20. Heikinheimo M., Lawshe A., Shackleford G.M., Wilson D.B., and MacArthur C.A. Fgf-8 expression in the post-gastrulation mouse suggests roles in the development of the face, limbs and central nervous system. Mech Dev 48 (1994) 129-138
21. Crossley P.H., and Martin G.R. The mouse Fgf8 gene encodes a family of polypeptides and is expressed in regions that direct outgrowth and patterning in the developing embryo. Development 121 (1995) 439-451
22. Sun X., Meyers E.N., Lewandoski M., and Martin G.R. Targeted disruption of Fgf8 causes failure of cell migration in the gastrulating mouse embryo. Genes Dev 13 (1999) 1834-1846
23. Haraguchi R., Suzuki K., Murakami R., Sakai M., Kamikawa M., Kengaku M., et al. Molecular analysis of external genitalia formation: the role of fibroblast growth factor (Fgf) genes during genital tubercle formation. Development 127 (2000) 2471-2479
24. Lewandoski M., Sun X., and Martin G.R. Fgf8 signalling from the AER is essential for normal limb development. Nat Genet 26 (2000) 460-463
25. Macatee T.L., Hammond B.P., Arenkiel B.R., Francis L., Frank D.U., and Moon A.M. Ablation of specific expression domains reveals discrete functions of ectoderm- and endoderm-derived FGF8 during cardiovascular and pharyngeal development. Development 130 (2003) 6361-6374
26. Perantoni A.O., Timofeeva O., Naillat F., Richman C., Pajni-Underwood S., Wilson C., et al. Inactivation of FGF8 in early mesoderm reveals an essential role in kidney development. Development 132 (2005) 3859-3871
27. Baker R.E., Schnell S., and Maini P.K. A clock and wavefront mechanism for somite formation. Dev Biol 293 (2006) 116-126
28. Powers C.J., McLeskey S.W., and Wellstein A. Fibroblast growth factors, their receptors and signaling. Endocr Relat Cancer 7 (2000) 165-197
29. Payson R.A., Jackson W., Liu Y., and Chiu I. The human FGF-8 gene localizes on chromosome 10q24 and is subjected to induction by androgen in breast cancer cells. Oncogene 13 (1996) 47-53
30. MacArthur C.A., Lawshe A., Xu J., Santos-Ocampo S., Heikinheimo M., Chellaiah A.T., et al. FGF-8 isoforms activate receptor splice forms that are expressed in mesenchymal regions of mouse development. Development 121 (1995) 3603-3613
31. MacArthur C.A., Shankar D.B., and Shackleford G.M. Fgf-8 activated by proviral insertion, cooperates with the Wnt-1 transgene in murine mammary tumorigenesis. J Virol 69 (1995) 2501-2507
32. Gemel J., Gorry M., Ehrlich G.D., and MacArthur C.A. Structure and sequence of human FGF8. Genomics 35 (1996) 253-257
33. MacArthur C.A., Lawshe A., Shankar D.B., Heikinheimo M., and Shackleford G.M. FGF-8 isoforms differ in NIH-3T3 cell transforming potential. Cell Growth Differ 6 (1995) 817-825
34. Sato T., Araki I., and Nakamura H. Inductive signal and tissue responsiveness defining the tectum and the cerebellum. Development 128 (2001) 2461-2469
35. Olsen S.K., Li J.Y., Bromleigh C., Eliseenkova A.V., Ibrahimi O.A., Lao Z., et al. Structural basis by which alternative splicing modulates the organizer activity of FGF8 in the brain. Genes Dev 20 (2006) 185-198
36. Orr-Urtreger A., Bedford M.T., Burakova T., Arman E., Zimmer Y., Yayon A., et al. Developmental localization of the splicing alternatives of fibroblast growth factor receptor-2 (FGFR-2). Dev Biol 158 (1993) 475-486
37. Ornitz D.M., Xu J., Colvin J.S., McEwen D.G., MacArthur C.A., Coulier F., et al. Receptor specificity of the fibroblast growth factor family. J Biol Chem 271 (1996) 15292-15297
38. Kouhara H., Koga M., Kasayama S., Tanaka A., Kishimoto T., and Sato B. Transforming activity of a newly cloned androgen-induced growth factor. Oncogene 9 (1994) 455-462
39. Blunt A.G., Lawshe A., Cunningham M.L., Seto M.L., Ornitz D.M., and MacArthur C. Overlapping expression and redundant activation of mesenchymal fibroblast growth factor (FGF) receptors by alternatively spliced FGF-8 ligands. J Biol Chem 272 (1997) 3733-3738
40. Kreuger J., Jemth P., Sanders-Lindberg E., Eliahu L., Ron D., Basilico C., et al. Fibroblast growth factors share binding sites in heparan sulphate. Biochem J 389 (2005) 145-150
41. Szebenyi G., and Fallon J.F. Fibroblast growth factors as multifunctional signaling factors. Int Rev Cytol 185 (1999) 45-106
42. Loo B.M., and Salmivirta M. Heparin/Heparan sulfate domains in binding and signaling of fibroblast growth factor 8b. J Biol Chem 277 (2002) 32616-32623
43. Viklund L., Vorontsova N., Henttinen T., and Salmivirta M. Syndecan-1 regulates FGF8b responses in S115 mammary carcinoma cells. Growth Factors 24 (2006) 151-157
44. Chambers D., Medhurst A.D., Walsh F.S., Price J., and Mason I. Differential display of genes at the midbrain-hindbrain junction identifies sprouty2: an FGF8-inducible member of a family of intracellular FGF antagonists. Mol Cell Neurosci 15 (2000) 22-35
45. Casci T., Vinos J., and Freeman M. Sprouty, an intracellular inhibitor of Ras signaling. Cell 96 (1999) 655-665
46. Preger E., Ziv I., Shabtay A., Sher I., Tsang M., Dawid I.B., et al. Alternative splicing generates an isoform of the human Sef gene with altered subcellular localization and specificity. Proc Natl Acad Sci USA 101 (2004) 1229-1234
47. Kovalenko D., Yang X., Nadeau R.J., Harkins L.K., and Friesel R. Sef inhibits fibroblast growth factor signaling by inhibiting FGFR1 tyrosine phosphorylation and subsequent ERK activation. J Biol Chem 278 (2003) 14087-14091
48. Tsang M., Friesel R., Kudoh T., and Dawid I.B. Identification of Sef, a novel modulator of FGF signalling. Nat Cell Biol 4 (2002) 165-169
49. Kim Y., Rice A.E., and Denu J.M. Intramolecular dephosphorylation of ERK by MKP3. Biochemistry 42 (2003) 15197-15207
50. Yamanishi H., Tanaka A., Miyamoto K., Takeda M., Nishizawa Y., Koga M., et al. An essential role of androgen-induced growth factor in glucocorticoid-dependent autocrine loop in Shionogi carcinoma 115 cells. J Steroid Biochem Mol Biol 52 (1995) 49-53
51. Sato B., Kouhara H., Koga M., Kasayama S., Saito H., Sumitani S., et al. Androgen-induced growth factor and its receptor: demonstration of the androgen-induced autocrine loop in mouse mammary carcinoma cells. J Steroid Biochem Mol Biol 47 (1993) 91-98
52. Koga M., Kasayama S., Matsumoto K., and Sato B. Molecular mechanism of androgen-dependent growth in transformed cells. Pathway from basic science to clinical application. J Steroid Biochem Mol Biol 54 (1995) 1-6
53. Härkönen P.L., Laaksonen E.I., Valve E.M., Solic N., and Darbre P.D. Temperature-sensitive mutants for steroid-sensitive growth of S115 mouse mammary tumor cells. Exp Cell Res 186 (1990) 288-298
54. Ruohola J.K., Valve E.M., Vainikka S., Alitalo K., and Härkönen P.L. Androgen and fibroblast growth factor (FGF) regulation of FGF receptors in S115 mouse mammary tumor cells. Endocrinology 136 (1995) 2179-2188
55. Minesita T., and Yamaguchi K. An androgen-dependent mouse mammary tumor. Cancer Res 25 (1965) 1168-1175
56. Kapoun A.M., and Shackleford G.M. Preferential activation of Fgf8 by proviral insertion in mammary tumors of Wnt1 transgenic mice. Oncogene 14 (1997) 2985-2989
57. Valve E.M., Tasanen M.J., Ruohola J.K., and Harkonen P.L. Activation of Fgf8 in S115 mouse mammary tumor cells is associated with genomic integration of mouse mammary tumor virus. Biochem Biophys Res Commun 250 (1998) 805-808
58. Erdreich-Epstein A., Ganguly A.K., Shi X.H., Zimonjic D.B., and Shackleford G.M. Androgen inducibility of Fgf8 in Shionogi carcinoma 115 correlates with an adjacent t(5;19) translocation. Genes Chromosomes Cancer 45 (2006) 169-181
59. Gnanapragasam V.J., Robson C.N., Neal D.E., and Leung H.Y. Regulation of FGF8 expression by the androgen receptor in human prostate cancer. Oncogene 21 (2002) 5069-5080
60. Wang Q., Stamp G.W., Powell S., Abel P., Laniado M., Mahony C., et al. Correlation between androgen receptor expression and FGF8 mRNA levels in patients with prostate cancer and benign prostatic hypertrophy. J Clin Pathol 52 (1999) 29-34
61. Tanaka A., Kamiakito T., Takayashiki N., Sakurai S., and Saito K. Fibroblast growth factor 8 expression in breast carcinoma: associations with androgen receptor and prostate-specific antigen expressions. Virchows Arch 441 (2002) 380-384
62. Brondani V., and Hamy F. Retinoic acid switches differential expression of FGF8 isoforms in LNCaP cells. Biochem Biophys Res Commun 272 (2000) 98-103
63. Brondani V., Klimkait T., Egly J., and Hamy F. Promoter of FGF8 reveals a unique regulation by unliganded RAR-alpha. J Mol Biol 319 (2002) 715-728
64. Kawata H., Kamiakito T., Takayashiki N., and Tanaka A. Vitamin D3 suppresses the androgen-stimulated growth of mouse mammary carcinoma SC-3 cells by transcriptional repression of fibroblast growth factor 8. J Cell Physiol 207 (2006) 793-799
65. Takayashiki N., Kawata H., Kamiakito T., and Tanaka A. Transcriptional repression of fibroblast growth factor 8 by transforming growth factor-beta in androgen-dependent SC-3 cells. J Steroid Biochem Mol Biol 96 (2005) 1-12
66. Hu T., Yamagishi H., Maeda J., McAnally J., Yamagishi C., and Srivastava D. Tbx1 regulates fibroblast growth factors in the anterior heart field through a reinforcing autoregulatory loop involving forkhead transcription factors. Development 131 (2004) 5491-5502
67. Beermann F., Kaloulis K., Hofmann D., Murisier F., Bucher P., and Trumpp A. Identification of evolutionarily conserved regulatory elements in the mouse Fgf8 locus. Genesis 44 (2006) 1-6
68. Armstrong K., Robson C.N., and Leung H.Y. NF-kappaB activation upregulates fibroblast growth factor 8 expression in prostate cancer cells. Prostate 66 (2006) 1223-1234
69. Grieshammer U., Cebrian C., Ilagan R., Meyers E., Herzlinger D., and Martin G.R. FGF8 is required for cell survival at distinct stages of nephrogenesis and for regulation of gene expression in nascent nephrons. Development 132 (2005) 3847-3857
70. Kang Y., and Massague J. Epithelial-mesenchymal transitions: twist in development and metastasis. Cell 118 (2004) 277-279
71. Dubrulle J., and Pourquie O. FGF8 mRNA decay establishes a gradient that couples axial elongation to patterning in the vertebrate embryo. Nature 427 (2004) 419-422
72. Dubrulle J., McGrew M.J., and Pourquie O. FGF signalling controls somite boundary position and regulates segmentation clock control of spatiotemporal Hox gene activation. Cell 106 (2001) 219-232
73. Li H.Y., Bourdelas A., Carron C., Gomez C., Boucaut J.C., and Shi D.L. FGF8, Wnt8 and Myf5 are target genes of Tbx6 during anteroposterior specification in Xenopus embryo. Dev Biol 290 (2006) 470-481
74. Albertson R.C., and Yelick P.C. Roles for fgf8 signaling in left-right patterning of the visceral organs and craniofacial skeleton. Dev Biol 283 (2005) 310-321
75. Crossley P.H., Minowada G., MacArthur C.A., and Martin G.R. Roles for FGF8 in the induction, initiation, and maintenance of chick limb development. Cell 84 (1996) 127-136
76. Crossley P.H., Martinez S., and Martin G.R. Midbrain development induced by FGF8 in the chick embryo. Nature 380 (1996) 66-68
77. Echevarria D., Belo J.A., and Martinez S. Modulation of Fgf8 activity during vertebrate brain development. Brain Res Brain Res Rev 49 (2005) 150-157
78. Nakamura H., Katahira T., Matsunaga E., and Sato T. Isthmus organizer for midbrain and hindbrain development. Brain Res Brain Res Rev 49 (2005) 120-126
79. Trumpp A., Depew M.J., Rubenstein J.L., Bishop J.M., and Martin G.R. Cre-mediated gene inactivation demonstrates that FGF8 is required for cell survival and patterning of the first branchial arch. Genes Dev 13 (1999) 3136-3148
80. Kawaguchi S., Shou J., Santos R., Hebert J.M., McConnell S.K., Mason I., et al. Fgf8 expression defines a morphogenetic center required for olfactory neurogenesis and nasal cavity development in mouse. Development 132 (2005) 5211-5223
81. Frank D.U., Fortheringham L.K., Brewer J.A., Muglia L.J., Tristani-Firouzi M., Capecchi M.R., et al. An FGF8 mouse mutant phenocopies human 22q11 deletion syndrome. Development 129 (2002) 4591-4603
82. Martin G. Making a vertebrate limb: new players enter from the wings. BioEssays 23 (2001) 865-868
83. Schmitt J.F., Hearn M.T., and Risbridger G.P. Expression of fibroblast growth factor-8 in adult rat tissues and human prostate carcinoma cells. J Steroid Biochem Mol Biol 57 (1996) 173-178
84. Buratini Jr. J., Teixeira A.B., Costa I.B., Glapinski V.F., Pinto M.G., Giometti I.C., et al. Expression of fibroblast growth factor-8 and regulation of cognate receptors, fibroblast growth factor receptor-3c and -4, in bovine antral follicles. Reproduction 130 (2005) 343-350
85. Valta M.P., Hentunen T., Qu Q., Valve E.M., Harjula A., Seppänen J.A., et al. Regulation of osteoblast differentiation: a novel function for fibroblast growth factor-8. Endocrinology 147 (2006) 2171-2182
86. Rudra-Ganguly N., Zheng J., Hoang A.T., and Roy-Burman P. Downregulation of FGF8 activity by antisense constructs in murine fibroblastic and human prostatic carcinoma cell systems. Oncogene 16 (1998) 1487-1492
87. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 285 (1971) 1182-1186
88. Jain R. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 307 (2005) 58-62
89. Hanahan D., and Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86 (1996) 353-364
90. Jain R., Schlenger K., Hockel M., and Yuan F. Quantitative angiogenesis assays: progress and problems. Nat Med 3 (1997) 1203-1208
91. Kanda S., Landgren E., Ljungström M., and Claesson-Welsh L. Fibroblast growth factor receptor 1-induced differentiation of endothelial cell line established from tsA58 large T transgenic mice. Cell Growth Differ 7 (1996) 383-395
92. Kanda S., Tomasini-Johansson B., Klint P., Dixelius J., Rubin K., and Claesson-Welsh L. Signaling via fibroblast growth factor receptor 1 is dependent on extracellular matrix in capillary endothelial cell differentiation. Exp Cell Res 248 (1999) 203-213
93. Mattila M.M., Tarkkonen K.M., Seppänen J.A., Ruohola J.K., Valve E.M., and Härkönen P.L. Androgen and fibroblast growth factor 8 (FGF8) downregulation of thrombospondin 1 (TSP1) in mouse breast cancer cells. Mol Cell Endocrinol 253 (2006) 36-43
94. West A.F., O'Donnell M., Charlton R.G., Neal D.E., and Leung H.Y. Correlation of vascular endothelial growth factor expression with fibroblast growth factor-8 expression and clinico-pathologic parameters in human prostate cancer. Br J Cancer. 85 (2001) 576-583
95. Ornitz D.M. FGF signaling in the developing endochondral skeleton. Cytokine Growth Factor Rev 16 (2005) 205-213
96. Mattila M, Laitala-Leinonen T, Büki K, Selander K, Tuomela J, Virtanen S, et al. Fibroblast growth factor 8 induces osteoclast differentiation in vitro and increases experimental bone metastasis of MDA-MB-231 cells in vivo in nude mice. Abstract #3973, AACR, Annual Meeting 2006.
97. Leung H.Y., Dickson C., Robson C.N., and Neal D.E. Over-expression of fibroblast growth factor-8 in human prostate cancer. Oncogene 12 (1996) 1833-1835
98. Kwabi-Addo B., Ozen M., and Ittmann M. The role of fibroblast growth factors and their receptors in prostate cancer. Endocr Relat Cancer 11 (2004) 709-724
99. Dorkin T.J., Robinson M.C., Marsh C., Neal D.E., and Leung H.Y. aFGF immunoreactivity in prostate cancer and its co-localization with bFGF and FGF8. J Pathol 189 (1999) 564-569
100. Somboonporn W., and Davis S.R. Testosterone effects on the breast: implications for testosterone therapy for women. Endocr Rev 25 (2004) 374-388
101. Suzuki K., Tokue A., Kamiakito T., Kuriki K., Saito K., and Tanaka A. Predominant expression of fibroblast growth factor (FGF)8, FGF4, and FGF receptor 1 in nonseminomatous and highly proliferative components of testicular germ cell tumors. Virchows Arch 439 (2001) 616-621
102. Giri D., Ropiquet F., and Ittmann M. Alterations in expression of basic fibroblast growth factor (FGF) 2 and its receptor FGFR-1 in human prostate cancer. Clin Cancer Res 5 (1999) 1063-1071
103. Wang F., McKeehan K., Yu C., and McKeehan W.L. Fibroblast growth factor receptor 1 phosphotyrosine 766: molecular target for prevention of progression of prostate tumors to malignancy. Cancer Res 62 (2002) 1898-1903
104. Freeman K.W., Welm B.E., Gangula R.D., Rosen J.M., Ittmann M., Greenberg N.M., et al. Inducible prostate intraepithelial neoplasia with reversible hyperplasia in conditional FGFR1-expressing mice. Cancer Res 63 (2003) 8256-8263
105. Wang F., McKeehan K., Yu C., Ittmann M., and McKeehan W.L. Chronic activity of ectopic type 1 fibroblast growth factor receptor tyrosine kinase in prostate epithelium results in hyperplasia accompanied by intraepithelial neoplasia. Prostate 58 (2004) 1-12
106. Edwards J., Krishna N.S., Witton C.J., and Bartlett J.M. Gene amplifications associated with the development of hormone-resistant prostate cancer. Clin Cancer Res 9 (2003) 5271-5281
107. Kwabi-Addo B., Wang J., Erdem H., Vaid A., Castro P., Ayala G., et al. Expression of Sprouty1, an inhibitor of fibroblast growth factor signal transduction, is decreased in human prostate cancer. Cancer Res 64 (2001) 4728-4735
108. 388 allele is associated with prostate cancer initiation and progression. Clin Cancer Res 10 (2004) 6169-6178
109. Bange J., Prechtl D., Cheburkin Y., Specht K., Harbeck N., Schmitt M., et al. Cancer progression and tumor cell motility are associated with the FGFR4 Arg(388) allele. Cancer Res 62 (2002) 840-847
110. Adnane J., Gaudray P., Dionne C.A., Crumley G., Jaye M., Schlessinger J., et al. BEK and FLG, two receptors to members of the FGF family, are amplified in subsets of human breast cancers. Oncogene 6 (1991) 659-663
111. Jaakkola S., Salmikangas P., Nylund S., Partanen J., Armstrong E., Pyrhönen S., et al. Amplification of fgfr4 gene in human breast and gynecological cancers. Int J Cancer 54 (1993) 378-382
112. Theillet C., Adelaide J., Louason G., Bonnet-Dorion F., Jacquemier J., Adnane J., et al. FGFR1 and PLAT genes and DNA amplification at 8p12 in breast and ovarian cancers. Genes Chromosomes Cancer 7 (1993) 219-226
113. Penault-Llorca F., Bertucci F., Adelaide J., Parc P., Coulier F., Jacquemier J., et al. Expression of FGF and FGF receptor genes in human breast cancer. Int J Cancer 61 (1995) 170-176
114. Yoshimura N., Sano H., Hashiramoto A., Yamada R., Nakajima H., Kondo M., et al. The expression and localization of fibroblast growth factor-1 (FGF-1) and FGF receptor-1 (FGFR-1) in human breast cancer. Clin Immunol Immunopathol 89 (1998) 28-34
115. Luqmani Y.A., Graham M., and Coombes R.C. Expression of basic fibroblast growth factor, FGFR1 and FGFR2 in normal and malignant human breast, and comparison with other normal tissues. Br J Cancer 66 (1992) 273-280
116. Jacquemier J., Adelaide J., Parc P., Penault-Llorca F., Planche J., deLapeyriere O., et al. Expression of the FGFR1 gene in human breast-carcinoma cells. Int J Cancer 59 (1994) 373-378
117. Hughes S.E. Differential expression of the fibroblast growth factor receptor (FGFR) multigene family in normal human adult tissues. J Histochem Cytochem 45 (1997) 1005-1019
118. La Rosa S., Sessa F., Colombo L., Tibiletti M.G., Furlan D., and Capella C. Expression of acidic fibroblast growth factor (aFGF) and fibroblast growth factor receptor 4 (FGFR4) in breast fibroadenomas. J Clin Pathol 54 (2001) 37-41
119. Abu-Issa R., Smyth G., Smoak I., Yamamura K., and Meyers E.N. Fgf8 is required for pharyngeal arch and cardiovascular development in the mouse. Development 129 (2002) 4613-4625